A New Option For The Treatment Of Malignant Pleural Mesothelioma (MPM)

A New Option For The Treatment Of Malignant Pleural Mesothelioma (MPM)
Raltitrexed (Tomudex┬«) in combination with cisplatin in the treatment of MPM improves median overall survival compared to treatment with cisplatin alone.1 With incidence rates expected to double over the next 20 years in many countries2, new and effective treatments are a welcome addition, concluded an eminent panel of international speakers at a symposium sponsored by Hospira at the 35th …
Read more on Medical News Today

Comments are closed.

Categories